Walder Wyss advised Crédit Mutuel Equity, the international direct investment company of Crédit Mutuel Alliance Fédérale, in its Pacovis minority stake acquisition. As a result of a shareholder change
Advestra advised Barry Callebaut on the placement of CHF 730 million bonds in the Swiss market on 17 May 2024. In addition, Barry Callebaut issued Eurobonds in the amount of EUR 700 mil
Advestra advised Viseca on the placement of CHF 165 million 1.65% senior bonds due 2028, which were issued by Viseca Payment Services. Zürcher Kantonalbank, Raiffeisen Schweiz
MLL advised Vsquared Ventures as lead investor in the USD 11 million seed financing round of Synthara, advised by Kellerhals Carrard. The financing successfully closed on 5 June 2024 and included OTB Ventures, Onsight Ventures, Deep Tech Labs,
Walder Wyss advised Helvetia on a successfully placed CHF 230 million senior bond with maturity in 2034 and a 1.95% coupon. The bond, guaranteed by Helvetia, will be used for general corporate purposes, including possible refinancings of outstanding
Niederer Kraft Frey (NKF) acted as an advisor for Index Ventures on its investment in EthonAI. EthonAI, a pioneer in AI-powered manufacturing analytics, has closed a $16.5 million (CHF 15 million) Series A financing led by Index
Lenz & Staehelin advised the underwriters on ADC’s sale of 13.4 million shares of its common stock and pre-funded warrants to purchase 8.1 million shares of its common stock in an underwritten offering for gross proceeds
Last June, the Swiss Competition Commission (ComCo) launched an investigation into Mastercard’s domestic card-present interchange fees for its Debit and Maestro debit card products. In the meantime, Mastercard has been able to reach an
Advestra advised Wille Finance, an international Swiss-based family office focusing on private equity / venture capital, real estate and listed assets, on its anchor investment in SwissComply, a provider of outsourcing solutions for
Walder Wyss advised the funds managed by Perceptive Advisor, a privately owned hedge fund sponsor investing in biotechnology and life sciences sectors, on the secured term loan financing for up USD 50,000,000 granted to Sophia Genetics,
